Danmei Pang
-
- Breast Cancer Treatment Studies 3
- Cancer-related molecular mechanisms research 2
-
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 2
-
- Advanced Breast Cancer Therapies 5
-
- Angiogenesis and VEGF in Cancer 3
- RNA modifications and cancer 2
- Co-authors
- Jifeng FengXiaojia WangBinghe XuSi SunJoseph RagazQunling ZhangZhongsheng TongZefei Jiang
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Danmei Pang
14 papers receiving 353 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 113
- Oncology 196
- Pulmonary and Respiratory Medicine 151
- Hepatology 21
- Pathology and Forensic Medicine 43
Countries citing papers authored by Danmei Pang
This map shows the geographic impact of Danmei Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danmei Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danmei Pang more than expected).
Fields of papers citing papers by Danmei Pang
This network shows the impact of papers produced by Danmei Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danmei Pang. The network helps show where Danmei Pang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danmei Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 17 | |
| 4 | 2022 | 3 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 3 | |
| 9 | 2019 | 17 | |
| 10 | 2018 | 28 | |
| 11 | 2018 | 31 | |
| 12 | 2018 | 14 | |
| 13 | [Effects of Modified Ruji Recipe in Preventing Relapse and Metastasis of Breast Cancer Patients with Negative Hormone Receptor]. | 2017 | 2 |
| 14 | 2017 | 2 | |
| 15 | 2016 | 0 | |
| 16 | 2014 | 218 | |
| 17 | 2013 | 3 |
About Danmei Pang
Danmei Pang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 357 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Angiogenesis and VEGF in Cancer (3 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Cancer Research (113 citations), Oncology (196 citations) and Pulmonary and Respiratory Medicine (151 citations). Danmei Pang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Jifeng Feng, Xiaojia Wang, Binghe Xu, Si Sun, Joseph Ragaz, Qunling Zhang, Zhongsheng Tong, Zefei Jiang, Minhao Fan and Jin Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.